Indegene

Indegene Financial Leverage

The Financial Leverage (Equity Multiplier) of Indegene (INDGN.NS) as of Oct 22, 2026 is 1.47. In the previous year, Financial Leverage (Equity Multiplier) was 1.27 — a change of 15.77% (higher).

Financial Leverage

1.47

YoY

15.77%

Last updated:

Financial Leverage (Equity Multiplier) of Indegene is 2026 1.47 . Financial Leverage (Equity Multiplier) of Indegene was 2025 1.27 . It decreases by 15.77% higher compared to the previous year.

The Indegene Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2020
-5.73 INR
Jan 1, 2021
1.84 INR
Jan 1, 2022
1.77 INR
Jan 1, 2023
2.07 INR
Jan 1, 2024
1.78 INR
Jan 1, 2025
1.27 INR
Jan 1, 2026
1.47 INR
The Indegene Financial Leverage history
YEARFinancial LeverageYoY
1.47+15.77%
1.27-28.61%
1.78-14.03%
2.07+16.94%
1.77-3.54%
1.84-132.03%
-5.73—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Indegene Stock analysis

What does Indegene do? Indegene Ltd generates revenue by providing digital-led commercialization services to life sciences companies, including biopharmaceutical, emerging biotech, and medical devices firms. The company assists these clients with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and the sales and marketing of their products. This comprehensive support structure allows Indegene to serve as a key partner in the end-to-end commercialization process for its diverse client base within the life sciences sector. The company monetizes its offerings through specialized solution segments such as Omnichannel Activation, which helps life sciences companies leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. Additionally, Enterprise Commercial Solutions primarily involves assisting life sciences companies with their digital marketing operations, further expanding the company's service portfolio and revenue streams. Revenue is also derived from Enterprise Medical Solutions, where Indegene establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. The company rounds out its business model by offering enterprise clinical solutions and consultancy services, ensuring a holistic service delivery model that addresses various operational needs of its customers in the life sciences industry. Indegene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Indegene stock

Financial Leverage (Equity Multiplier) of Indegene is 1.47 in 2026.

Financial Leverage (Equity Multiplier) of Indegene changed from 1.27 to 1.47, representing a 15.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Indegene since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Indegene with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Indegene

All Key Metrics — Indegene